A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
The main purpose of this study is to determine the efficacy and safety of LY3972406 in adult participants with moderate-to-severe plaque psoriasis.
Key RequirementsClinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.
Have moderate-to-severe chronic plaque psoriasis for at least 6 months prior to baseline
Able to swallow oral medication
Have at least 1 skin lesion for skin biopsy
Participants Must Not:
Had a significant flare of psoriasis during the 12 weeks before baseline
Have any other skin conditions
Have a current or recent acute, active infection
Have systemic lupus
Lilly Trial Alerts
Take the Next Step
- Select which clinical trial site works best for you.
- Share your details and questionnaire directly with site(s) that allow this.
- Get contact details for the site(s) of your choice.
Completing the Trial Match questionnaire doesn’t mean that you will be enrolled in a study. There may be more eligibility criteria for the study which are assessed by the Lilly clinical team.
Clinical Trial Resources
You will complete the questionnaire on another website.YesNo